Cellbxhealth PLC — RNS

Regulatory news across CLBX

Date	Time	Date	TitleTitle (filtered)	Source
27/06/22	07:00:08	27 Jun 2022	Spread of breast cancer accelerates during sleep	Spread of breast cancer accelerates during sleep	RNS
23/06/22	18:24:58	23 Jun 2022	Issue of Equity	Issue of Equity	RNS
22/06/22	07:00:06	22 Jun 2022	Secured contract from pharma services customer	Secured contract from pharma services customer	RNS
16/06/22	07:00:09	16 Jun 2022	Predicting immunotherapy response in SCLC	Predicting immunotherapy response in SCLC	RNS
14/06/22	07:00:07	14 Jun 2022	Potential role of invasive cellular protrusions	Potential role of invasive cellular protrusions	RNS
30/05/22	07:00:07	30 May 2022	Partnership with major United States urology group	Partnership with major United States urology group	RNS
27/05/22	07:00:07	27 May 2022	Molecular characterisation of CTCs	Molecular characterisation of CTCs	RNS
25/05/22	16:35:20	25 May 2022	Price Monitoring Extension	Price Monitoring Extension	RNS
25/05/22	12:30:35	25 May 2022	ANGLE receives FDA clearance for Parsortix	ANGLE receives FDA clearance for Parsortix	RNS
20/05/22	07:00:08	20 May 2022	Prostate Cancer UK funds new study using Parsortix	Prostate Cancer UK funds new study using Parsortix	RNS
28/04/22	07:00:12	28 Apr 2022	Preliminary Results	Preliminary Results	RNS
20/04/22	07:00:05	20 Apr 2022	Notice of Preliminary Results and Webcast	Notice of Preliminary Results and Webcast	RNS
14/04/22	07:00:06	14 Apr 2022	Poster on Parsortix system presented at AACR 2022	Poster on Parsortix system presented at AACR 2022	RNS
01/04/22	07:00:10	1 Apr 2022	Identifying drug targets in cancer metastasis	Identifying drug targets in cancer metastasis	RNS
29/03/22	07:00:11	29 Mar 2022	Rapid information on patient response to therapies	Rapid information on patient response to therapies	RNS
25/03/22	07:00:07	25 Mar 2022	Identifying therapeutic targets in TNBC patients	Identifying therapeutic targets in TNBC patients	RNS
15/03/22	07:00:07	15 Mar 2022	Update on laboratory accreditation	Update on laboratory accreditation	RNS
09/03/22	16:41:33	9 Mar 2022	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
09/03/22	16:36:10	9 Mar 2022	Price Monitoring Extension	Price Monitoring Extension	RNS
02/03/22	18:29:01	2 Mar 2022	Holding(s) in Company	Holding(s) in Company	RNS
18/02/22	17:13:01	18 Feb 2022	Issue of Equity	Issue of Equity	RNS
21/01/22	07:00:16	21 Jan 2022	Potential in immunotherapy treatment selection	Potential in immunotherapy treatment selection	RNS
17/01/22	07:00:08	17 Jan 2022	Concordance of Parsortix with tissue biopsy	Concordance of Parsortix with tissue biopsy	RNS
13/01/22	07:00:05	13 Jan 2022	Update on lab accreditation and ovarian study	Update on lab accreditation and ovarian study	RNS
10/01/22	07:00:10	10 Jan 2022	Insight into drug resistance in NSCLC	Insight into drug resistance in NSCLC	RNS
22/12/21	18:29:15	22 Dec 2021	Issue of Equity	Issue of Equity	RNS
01/12/21	18:11:04	1 Dec 2021	Issue of Equity	Issue of Equity	RNS
01/12/21	07:00:10	1 Dec 2021	Parsortix in RNA analysis of CTCs as tool in NSCLC	Parsortix in RNA analysis of CTCs as tool in NSCLC	RNS
26/11/21	17:33:54	26 Nov 2021	Issue of Equity	Issue of Equity	RNS
17/11/21	10:32:30	17 Nov 2021	Issue of Equity	Issue of Equity	RNS
15/11/21	07:00:07	15 Nov 2021	Issue of LTIP Options and Share Options	Issue of LTIP Options and Share Options	RNS
15/11/21	07:00:06	15 Nov 2021	Appointment of Chief Medical Officer	Appointment of Chief Medical Officer	RNS
12/11/21	17:51:20	12 Nov 2021	Issue of Equity	Issue of Equity	RNS
12/11/21	07:00:03	12 Nov 2021	Participation at Jefferies healthcare conference	Participation at Jefferies healthcare conference	RNS
11/11/21	07:00:04	11 Nov 2021	Parsortix system showcased at NCRI Festival	Parsortix system showcased at NCRI Festival	RNS
10/11/21	17:40:00	10 Nov 2021	Issue of Equity	Issue of Equity	RNS
02/11/21	07:00:05	2 Nov 2021	Change of Adviser	Change of Adviser	RNS
21/10/21	17:25:01	21 Oct 2021	Issue of Equity	Issue of Equity	RNS
15/10/21	17:45:17	15 Oct 2021	Issue of Equity	Issue of Equity	RNS
30/09/21	16:02:39	30 Sept 2021	Issue of Equity	Issue of Equity	RNS
30/09/21	07:00:10	30 Sept 2021	Interim Results	Interim Results	RNS
27/09/21	07:00:10	27 Sept 2021	Parsortix demonstrates ability to isolate CTCs	Parsortix demonstrates ability to isolate CTCs	RNS
22/09/21	07:00:05	22 Sept 2021	Study shows use of Parsortix to assess PD-L1	Study shows use of Parsortix to assess PD-L1	RNS
20/09/21	07:00:09	20 Sept 2021	Parsortix enables gene expression analysis in mPCa	Parsortix enables gene expression analysis in mPCa	RNS
07/09/21	07:00:04	7 Sept 2021	Notice of Interim Results and Webcast	Notice of Interim Results and Webcast	RNS
24/08/21	07:00:03	24 Aug 2021	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
09/08/21	07:00:08	9 Aug 2021	Study highlights superior performance of Parsortix	Study highlights superior performance of Parsortix	RNS
06/08/21	13:17:06	6 Aug 2021	Issue of Equity	Issue of Equity	RNS
03/08/21	15:13:49	3 Aug 2021	Issue of Equity	Issue of Equity	RNS
28/07/21	07:00:05	28 Jul 2021	Contract secured for bespoke assay development	Contract secured for bespoke assay development	RNS

Showing 151–200 of 474 announcements